StonvexLoading…
StonvexStonvexStonvexCore line items from APO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.06B | $32.05B | $22.18B | $12.36B |
Operating Income | $283.00M | $6.68B | $4.92B | $2.03B |
Net Income | $-1.91B | $3.49B | $2.81B | $1.07B |
EPS (Diluted) | $-3.27 | $5.54 | $4.47 | $1.67 |
Total Assets | $467.53B | $460.95B | $449.54B | $419.55B |
Total Liabilities | $428.00B | $418.43B | $409.75B | $385.69B |
Cash & Equivalents | $23.75B | $20.59B | $21.20B | $14.97B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 576.51M | 578.98M | 580.39M | 572.02M |